These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2367151)

  • 1. [Activity of cefuroxime against bacterial strains isolated from acute otitis media].
    Simonet M; Herrmann JL; Veron M
    Pathol Biol (Paris); 1990 May; 38(5):355-7. PubMed ID: 2367151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of cefapirin against bacterial strains isolated from acute otitis media in children].
    Simonet M; Herrmann JL; Gehanno P; Veron M
    Pathol Biol (Paris); 1990 May; 38(5):352-4. PubMed ID: 2114604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of cefuroxime-axetil in the treatment of respiratory tract infections. Bacteriological and pharmacological data].
    Bergogne-Berezin E; Vallée E; Muller-Serieys C
    Therapie; 1991; 46(4):333-7. PubMed ID: 1948811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
    Renkonen OV
    Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of oral cephalosporin BAY v 3522 compared with other oral cephalosporins.
    Locher R; Strässle A; Kayser FH
    Drugs Exp Clin Res; 1990; 16(10):515-25. PubMed ID: 2100734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM; Suter M; Borsos S
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
    Soriano F; Parra A; Cenjor C; Nieto E; García-Calvo G; Giménez MJ; Aguilar L; Ponte C
    J Infect Dis; 2000 Feb; 181(2):646-52. PubMed ID: 10669350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
    Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
    J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of bacterial pneumonias with cefuroxime-axetil. Predictive value of measurement of the in vitro susceptibility].
    Cluzel R; Portier H; Modaï J
    Pathol Biol (Paris); 1996 Mar; 44(3):217-23. PubMed ID: 8761613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].
    Fenoll A; Robledo O; Lerma M; Giménez MJ; Cebrián L; Casal J; Aguilar L; Gómez-Lus ML
    Rev Esp Quimioter; 2006 Mar; 19(1):39-44. PubMed ID: 16688290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological study of acute otitis media in children. Therapeutic consequences].
    Megraud F; De Lestapis X; Devars F; Traissac L
    Arch Fr Pediatr; 1987; 44(6):419-22. PubMed ID: 3650065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
    Laurans G; Gaudio F; Ducroix JP; Orfila J
    Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.